Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

TearScience gets up to $70mm in funding from HealthCare Royalty Partners

Executive Summary

Ophthalmology device developer TearScience Inc. has secured up to $70mm in a debt-structured financing from HealthCare Royalty Partners. The money will be used to commercialize TearScience’s LipiFlow system and establish the device as the standard-of-care for evaporative dry eye.
Deal Industry
  • Medical Devices
    • Monitoring Equipment & Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Other

Related Companies